Department of Tumor Biology, Karolinska Institutet, S-104 01, Stockholm, Sweden.
Immunogenetics. 1978 Dec;7(1):391-404. doi: 10.1007/BF01844030.
A spectrum of lymphomas, sarcomas, and carcinomas were tested for F(1) hybrid resistance after s.c. inoculation of small numbers of cells into syngeneic and F(1) hybrid mice. Significant F(1) resistance was demonstrated against all tumors tested except one. Backcross and/or congenic inoculation tests showed significantH-2 linkage of hybrid resistance against all lymphomas and leukemias tested. There was no linkage betweenH-2 and hybrid resistance within the more limited group of carcinomas and sarcomas. DifferentH-2-linked resistance genes were shown to act against different lymphomas, including some that were induced by the same agent. Some lymphomas induced by different agents in the same strain were also found to differ in their sensitivity to the sameH-2-linked resistance factor. These data suggest the existence of a polymorphic system, probably pseudoallelic, rather than simply allelic in nature.
经皮下接种少量细胞至同基因和 F1 杂交鼠后,对一系列淋巴瘤、肉瘤和癌进行 F1 杂种抗性检测。除一种肿瘤外,所有检测肿瘤均显示出显著的 F1 抗性。回交和/或同基因接种试验显示,针对所有检测的淋巴瘤和白血病,杂种抗性与 H-2 有显著的连锁关系。在范围更有限的癌和肉瘤组中,H-2 与杂种抗性之间没有联系。不同的 H-2 连锁抗性基因被证明可以针对不同的淋巴瘤发挥作用,包括一些由同一药物诱导的淋巴瘤。在同一品系中由不同药物诱导的一些淋巴瘤也被发现对同一 H-2 连锁抗性因子的敏感性不同。这些数据表明存在一个多态性系统,可能是假等位基因,而不是简单的等位基因性质。